Recent reports indicate that Robert F. Kennedy Jr. plans to suggest a potential link between Tylenol use during pregnancy and autism, prompting immediate concern among health officials and the public. Kenvue, the parent company of Tylenol, saw its stock prices tumble following these revelations. The U.S. Department of Health and Human Services (HHS) is also responding to the claims, emphasizing that current scientific research does not conclusively support a cause-and-effect relationship between acetaminophen and autism. Despite the lack of definitive evidence, pregnant women are facing increasing scrutiny and questions regarding the safety of this common pain reliever. Experts urge that more research is needed to fully understand the implications of acetaminophen use in pregnant women and its effects on child development.